• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Aplastic anemia (second of two parts): pathogenesis, diagnosis, treatment, and prognosis.

作者信息

Camitta B M, Storb R, Thomas E D

出版信息

N Engl J Med. 1982 Mar 25;306(12):712-8. doi: 10.1056/NEJM198203253061204.

DOI:10.1056/NEJM198203253061204
PMID:7038485
Abstract
摘要

相似文献

1
Aplastic anemia (second of two parts): pathogenesis, diagnosis, treatment, and prognosis.
N Engl J Med. 1982 Mar 25;306(12):712-8. doi: 10.1056/NEJM198203253061204.
2
Marrow transplantation for severe aplastic anemia: the Seattle experience.严重再生障碍性贫血的骨髓移植：西雅图的经验
Prog Clin Biol Res. 1984;148:297-313.
3
[Treatment and prognosis of aplastic anemia].再生障碍性贫血的治疗与预后
Saishin Igaku. 1969 Apr;24(4):749-56.
4
[Bone marrow transplantation and (or) immunosuppression with antithymocyte globulin in the treatment of aplastic anemia].[骨髓移植和（或）用抗胸腺细胞球蛋白进行免疫抑制治疗再生障碍性贫血]
Ned Tijdschr Geneeskd. 1978 Mar 11;122(10):326-32.
5
[Treatment of bone marrow aplasia by allogenic bone marrow grafts].[同种异体骨髓移植治疗骨髓再生障碍]
Nouv Presse Med. 1975 Apr 19;4(16):1177-82.
6
[Bone marrow transplantation for aplastic anemia--initial results in 8 patients].[再生障碍性贫血的骨髓移植——8例患者的初步结果]
Wien Klin Wochenschr. 1982 Oct 15;94(19):504-9.
7
[Diagnosis and treatment of idiopathic aplastic anemia in children].[儿童特发性再生障碍性贫血的诊断与治疗]
Zhongguo Dang Dai Er Ke Za Zhi. 2009 Feb;11(2):81-7.
8
Course of acquired aplastic anemia in children treated with supportive care.接受支持性治疗的儿童获得性再生障碍性贫血病程
JAMA. 1969 May 26;208(8):1372-8.
9
Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival.通过来自 HLA 相同同胞的骨髓移植治疗再生障碍性贫血。与移植物抗宿主病和生存相关的预后因素。
J Clin Invest. 1977 Apr;59(4):625-32. doi: 10.1172/JCI108680.
10
Treatment of 144 patients with severe aplastic anemia using immunosuppression and allogeneic marrow transplantation: a report from the international bone marrow transplant registry.使用免疫抑制和异基因骨髓移植治疗144例重型再生障碍性贫血患者：来自国际骨髓移植登记处的报告
Transplant Proc. 1981 Mar;13(1 Pt 1):227-9.

引用本文的文献

1
Protective factors, management and prognosis of mixed chimerism after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia in children.儿童重型再生障碍性贫血异基因造血干细胞移植后混合嵌合体的保护因素、管理及预后
Bone Marrow Transplant. 2025 Apr 6. doi: 10.1038/s41409-025-02577-3.
2
Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic Anemia.艾曲泊帕联合一线免疫抑制疗法治疗新诊断的重型再生障碍性贫血的长期疗效
J Hematol. 2024 Aug;13(4):142-149. doi: 10.14740/jh1289. Epub 2024 Aug 10.
3
Haploidentical hematopoietic stem cell transplantation as a first-line treatment for paediatric severe aplastic anemia: a single-center research.
Haploidentical 造血干细胞移植作为儿科重型再生障碍性贫血一线治疗：单中心研究。
Int J Med Sci. 2024 Apr 15;21(6):1027-1036. doi: 10.7150/ijms.94012. eCollection 2024.
4
Modified Delphi panel consensus recommendations for management of severe aplastic anemia.改良 Delphi 法-panel 共识推荐的再生障碍性贫血严重程度的管理建议。
Blood Adv. 2024 Aug 13;8(15):3946-3960. doi: 10.1182/bloodadvances.2023011642.
5
JAK inhibition in a patient with a STAT1 gain-of-function variant reveals STAT1 dysregulation as a common feature of aplastic anemia.在一名 STAT1 功能获得性变异患者中进行 JAK 抑制揭示 STAT1 失调是再生障碍性贫血的共同特征。
Med. 2022 Jan 14;3(1):42-57.e5. doi: 10.1016/j.medj.2021.12.003.
6
Upregulated Expression of Profilin1 on Dendritic Cells in Patients With Severe Aplastic Anemia.严重再生障碍性贫血患者树突状细胞中 Profilin1 的表达上调。
Front Immunol. 2021 Jun 16;12:631954. doi: 10.3389/fimmu.2021.631954. eCollection 2021.
7
Clinical diagnostic value of telomere length measurement in inherited bone marrow failure syndromes.端粒长度测量在遗传性骨髓衰竭综合征中的临床诊断价值
Haematologica. 2021 Sep 1;106(9):2511-2515. doi: 10.3324/haematol.2021.278334.
8
Upregulated expression of leukocyte immunoglobulin-like receptor A3 in patients with severe aplastic anemia.重型再生障碍性贫血患者白细胞免疫球蛋白样受体A3表达上调
Exp Ther Med. 2021 Apr;21(4):346. doi: 10.3892/etm.2021.9777. Epub 2021 Feb 11.
9
Effective Tacrolimus Treatment for Patients with Non-Severe Aplastic Anemia That is Refractory/Intolerant to Cyclosporine A: A Retrospective Study.他克莫司治疗环孢素 A 难治/不耐受的非重型再生障碍性贫血患者的疗效：一项回顾性研究。
Drug Des Devel Ther. 2020 Dec 30;14:5711-5719. doi: 10.2147/DDDT.S275975. eCollection 2020.
10
[Evaluation of the efficacy of cyclosporin A combined with recombined human thrombopoietin for treating patients with non-severe aplastic anemia].环孢素A联合重组人血小板生成素治疗非重型再生障碍性贫血的疗效评估
Zhonghua Xue Ye Xue Za Zhi. 2020 Aug 14;41(8):637-642. doi: 10.3760/cma.j.issn.0253-2727.2020.08.004.